Yazan Abou-Ismail/ LinkedIn
Jun 6, 2026, 23:30
Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared on LinkedIn:
”I had the opportunity to share some insights in this Medscape article on a snail-derived (Camaena cicatricose) compound being investigated as a potential novel anticoagulant with possibly improved bleeding profile.
So interesting!
Always great to see the landscape of thrombosis treatment evolve, and the interest in uncoupling thrombosis from hemostasis grow.
I weighed in on potential opportunities and some limitations.
Thank you Beth Rush for putting this together and including me!”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026